Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT01204125. IPD Sharing: Not stated. Countries: 3. Publications: 1.
Ipilimumab, Nivolumab, and Talimogene Laherparepvec Before Surgery in Treating Participants With Localized, Triple-Negative or Estrogen Receptor Positive, HER2 Negative Breast Cancer-deleted
ClinicalTrials.gov study NCT04185311. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Dose-dense EC Followed by ABX With PD-1 for Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT04418154. IPD Sharing: YES. Countries: 1. Publications: 1.
Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients
ClinicalTrials.gov study NCT02499367. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy of Capecitabine Metronomic Chemotherapy to Triple-negative Breast Cancer
ClinicalTrials.gov study NCT01112826. IPD Sharing: NO. Countries: 1. Publications: 3.
Triple Negative Breast Cancer Trial
ClinicalTrials.gov study NCT00532727. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT04613674. IPD Sharing: NO. Countries: 1. Publications: 1.
Xenografts Development from Surgical Tumor Samples of Patients with Triple Negative or Luminal B Breast Cancer
ClinicalTrials.gov study NCT04133077. IPD Sharing: NO. Countries: 1. Publications: 1.
Use of Imatinib to Convert Triple Negative Breast Cancer Into ER-positive Breast Cancer (I-CONIC)
ClinicalTrials.gov study NCT05722795. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy Study of MCS110 Given With Carboplatin and Gemcitabine in Advanced Triple Negative Breast Cancer (TNBC)
ClinicalTrials.gov study NCT02435680. IPD Sharing: UNDECIDED. Countries: 12. Publications: 0.
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadju
ClinicalTrials.gov study NCT05633654. IPD Sharing: NO. Countries: 8. Publications: 1.
Safety and Efficacy of IV Nerofe™ Followed by Doxorubicin, In Metastatic Ovarian Cancer and Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03634150. IPD Sharing: NO. Countries: 1. Publications: 1.
A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer
ClinicalTrials.gov study NCT00540358. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Salvage Chemotherapy of Vinorelbine Plus Oxaliplatin in Metastatic Triple-negative Breast Cancer:a Prospective Trial
ClinicalTrials.gov study NCT01528826. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Neoadjuvant Study of HIFU With or Without PD-1 Inhibitors Followed by Abraxane Plus Carboplatin in Triple-Negative Breast Cancer.
ClinicalTrials.gov study NCT07394387. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Carboplatin Intensified Chemotherapy for TRIple NEgative Breast Cancer(CITRINE)
ClinicalTrials.gov study NCT04296175. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Immunogenicity of a Personalized Polyepitope DNA Vaccine Strategy in Breast Cancer Patients With Persistent Triple-Negative Disease Following Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT02348320. IPD Sharing: NO. Countries: 1. Publications: 1.
Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients
ClinicalTrials.gov study NCT04068623. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Evaluate the Safety, Pharmacokinetics and Clinical Activity of RO6870810 and Atezolizumab (PD-L1 Antibody) in Participants With Advanced Ovarian Cancer or Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03292172. IPD Sharing: Not stated. Countries: 5. Publications: 1.
Neoadjuvant Treatment of Docetaxel, Anthracycline and Cyclophosphamide (TAC) Versus Docetaxel and Cyclophosphamide (TC) in Triple-Negative or Her2 Positive Breast Cancer
ClinicalTrials.gov study NCT00912444. IPD Sharing: Not stated. Countries: 1. Publications: 4.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.